Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7405 p709
17 June 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Commercial diets tested

Clinically beneficial weight loss is achievable through commercial programmes, according to a recent study (BMJ 2006;332:1309).

Researchers evaluated data from the BBC “diet trials”, which compared the Slim-Fast plan (meal replacement approach), Weight Watchers pure points programme (energy controlled diet with weekly group meetings), Dr Atkins’ new diet revolution (self monitored low carbohydrate plan) and Rosemary Conley’s eat yourself slim plan (low fat diet and weekly group exercise class) with a control group who retained their usual habits.

All the intervention groups saw weight loss, fat loss and reduction in waist circumference at all stages of the study, compared with controls (P<0.001). During the first four weeks, mean weight loss was higher in the Atkins group than in the other intervention groups (P<0.001). The authors found no harmful effects on total cholesterol or renal function for patients in the Atkins group, but the overall safety of the diet was not tested.

Back to Top


©The Pharmaceutical Journal